OMass Therapeutics Raises $310M to Advance Drug Pipeline
OXFORD, United Kingdom, October 15, 2026 OMass Therapeutics announced an oversubscribed $310 million (£230 million) Series C financing round...
Capital for New Therapy
Matchpoint Therapeutics Raises $150M Series B for Pipeline
WATERTOWN, Mass. — October 7, 2026 Matchpoint Therapeutics announced the successful closing of a $150 million Series B financing...
RougeTx Launches with $58M Series A for HHT Therapy
NAARDEN, Netherlands — October 6, 2026 RougeTx announced its launch with a $58 million Series A financing to advance...
AnaCardio Raises €62.5 Million Series B for AC01
STOCKHOLM, Sweden — September 30, 2026 AnaCardio announced the completion of a €62.5 million Series B financing co-led by...
Cardiol Therapeutics Files US$150M Shelf Prospectus
Toronto, Ontario, Canada, September 10, 2026 Cardiol Therapeutics Inc. has filed a US$150 million preliminary short form base shelf...
NovaGo Raises $30M to Advance Spinal Cord Therapy
Zurich, Switzerland, September 2, 2026 NovaGo Therapeutics, a Swiss clinical-stage biotechnology company developing antibody therapeutics for nerve growth and...
Kazia Raises Up to $120 Million to Advance Paxalisib
Sydney, Australia, August 31, 2026 Kazia Therapeutics Limited, an oncology-focused biotechnology company developing therapies designed to address cancer biology,...
BioLineRx Raises $3.75M to Advance Oncology Pipeline
TEL AVIV, Israel, Aug 28, 2026 BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on therapies for oncology and rare...
Revier Therapeutics Launches with €6M Cardiometabolic Funding
HEIDELBERG, Germany — August 25, 2026 Revier Therapeutics has officially launched operations following the closing of a €6 million...
Insilico Medicine Gains MSCI Global Small Cap Index Inclusion
Cambridge, Massachusetts, August 17, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced...